Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Filings indexed 2,308 across all filing types
Latest filing 2007-11-28 Regulatory Filings
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2007
Regulatory Filings
2007-11-28 Danish
Director's Dealing 2007
Director's Dealing Classification · 99% confidence The document explicitly details transactions made by a member of management ('Per Falholt, EVP, Research & Development') in the company's shares. It cites compliance with a specific securities trading act ('Section 28a of the Danish Securities Trading Act') and presents a table showing the date, type of transaction (Sell), number of shares, and market value. This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing type code is DIRS.
2007-11-28 English
Regulatory Filings 2007
Regulatory Filings
2007-11-27 Danish
Director's Dealing 2007
Director's Dealing Classification · 99% confidence The document text is titled 'LEDELSENS HANDEL MED NOVOZYMES A/S B-AKTIER' (Management's Trading in Novozymes A/S B-Shares) and explicitly details a transaction made by an EVP (Per Falholt) involving the purchase and sale of company shares on a specific date (26/11/2007). This directly corresponds to the definition of Director's Dealing, which covers personal share transactions by company directors and executives (insider trades). The relevant code is DIRS.
2007-11-27 English
Regulatory Filings 2007
Regulatory Filings
2007-11-26 Danish
Regulatory Filings 2007
Regulatory Filings
2007-11-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.